BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi RE, Massironi S, Conte D, Peracchi M. Therapy for metastatic pancreatic neuroendocrine tumors. Ann Transl Med 2014;2:8. [PMID: 25332984 DOI: 10.3978/j.issn.2305-5839.2013.03.01] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
Number Citing Articles
1 Huang G, Song W, Zhang Y, Ren B, Lv Y, Liu K. Construction and validation of a nomogram for patients with pancreatic neuroendocrine tumors: A population study of 5,927 patients. Front Gastroenterol 2023;1. [DOI: 10.3389/fgstr.2022.1088133] [Reference Citation Analysis]
2 Zhang W, Gao H, Liu W, Qin Y, Ye Z, Lou X, Wang F, Zhang Y, Chen X, Chen J, Yu X, Zhuo Q, Xu X, Ji S. A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival. Front Endocrinol 2022;13:941210. [DOI: 10.3389/fendo.2022.941210] [Reference Citation Analysis]
3 Canakis A, Lee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc 2022; 14(5): 267-290 [DOI: 10.4253/wjge.v14.i5.267] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Frey S, Mirallié E, Le Bras M, Regenet N. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel) 2021;13:5954. [PMID: 34885063 DOI: 10.3390/cancers13235954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Liu F, Guo X, Liu T, Xu X, Li N, Xiong C, Li C, Zhu H, Yang Z. Evaluation of Pan-SSTRs Targeted Radioligand [64Cu]NOTA-PA1 Using Micro-PET Imaging in Xenografted Mice. ACS Med Chem Lett 2020;11:445-50. [PMID: 32292548 DOI: 10.1021/acsmedchemlett.9b00544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Solassol I, Pinguet F, Quantin X. FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management. Biomolecules 2019;9:E668. [PMID: 31671561 DOI: 10.3390/biom9110668] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
7 Zubiri L, Bilbao JI, Rodríguez J, Sangro B. Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors. Hepat Oncol 2018;5:HEP09. [PMID: 31293777 DOI: 10.2217/hep-2017-0025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Yang Y, Sun Y, Wang H, Li H, Zhang M, Zhou L, Meng X, Wu Y, Liu P, Liu X, Zhang J, Tan X. MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer. Oncol Lett 2018;16:7295-301. [PMID: 30546469 DOI: 10.3892/ol.2018.9513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nigri G, Petrucciani N, Debs T, Mangogna LM, Crovetto A, Moschetta G, Persechino R, Aurello P, Ramacciato G. Treatment options for PNET liver metastases: a systematic review. World J Surg Oncol. 2018;16:142. [PMID: 30007406 DOI: 10.1186/s12957-018-1446-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
10 Pearman TP, Beaumont JL, Cella D, Neary MP, Yao J. Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden. Support Care Cancer 2016;24:3695-703. [PMID: 27029477 DOI: 10.1007/s00520-016-3189-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
11 Sandoval MA, Pagsisihan D, Berberabe A, Palugod-Lopez EG. A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma. BMJ Case Rep 2016;2016:bcr2016214702. [PMID: 26994053 DOI: 10.1136/bcr-2016-214702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Keutgen XM, Nilubol N, Glanville J, Sadowski SM, Liewehr DJ, Venzon DJ, Steinberg SM, Kebebew E. Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2016;159:311-318. [PMID: 26453135 DOI: 10.1016/j.surg.2015.05.042] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
13 Liu Z, Xu Y, Long J, Guo K, Ge C, Du R. microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1. Chin J Cancer Res 2015;27:247-57. [PMID: 26157321 DOI: 10.3978/j.issn.1000-9604.2015.04.07] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
14 Chen OT, Dojki FK, Weber SM, Hinshaw JL. Percutaneous Microwave Ablation of an Insulinoma in a Patient with Refractory Symptomatic Hypoglycemia. J Gastrointest Surg 2015;19:1378-81. [PMID: 25941027 DOI: 10.1007/s11605-015-2831-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
15 Tao Z, Cheng M, Hu H, Wang S, Su J, Lv W, Guo H, Tang J, Cao B. Altered Plasticity of Glycogen Phosphorylase in Forebrain Gliosomes Obtained from Insulinoma Patients. J Mol Neurosci 2015;57:21-7. [PMID: 25946981 DOI: 10.1007/s12031-015-0573-y] [Reference Citation Analysis]
16 Yi J, Yang X, Zheng L, Yang G, Sun L, Bao Y, Wu Y, Huang Y, Yu C, Yang SN, Li Y. Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio. Biosci Rep 2015;35:e00195. [PMID: 26182357 DOI: 10.1042/BSR20150028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]